Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Synairgen Share News (SNG)
SNG Share
Price
SNG Share
News
SNG Share
Chat
SNG Share
Trades103
SNG
Live RNS
SNG Share
Charts
SNG Broker
Ratings
SNG Directors
Deals
SNG Financial
Diary
SNG
Fundamentals
SNG Short
Positions
SNG
Media
SNG Company
Research
SNG Company
Timeline
- There is currently no data for SNG
Synairgen News
REFILE-UPDATE 2-Synairgen soars after drug shows promise in COVID-19 cases
(Refiles to correct spelling in the media identifier)* Shares hit all-time high on Monday* Company's drug cuts risk of severe COVID-19 by 79%* Some re...
UPDATE 2-Synairgen soars after drug shows promise in COVID-19 cases
* Shares hit all-time high on Monday* Company's drug cuts risk of severe COVID-19 by 79%* Some researchers caution on enthusiasm (Recasts, adds comme...
UPDATE 1-Synairgen shares soar as drug shows lower risk of severe COVID-19 cases
(Adds details on the trial, shares)July 20 (Reuters) - Synairgen Plc said on Monday its drug helped reduce the risk of severe cases in hospitalised ...
Europe open: Stocks reverse early losses, healthcare leads
(Sharecast News) - Stocks have recovered from early selling following news that European Union leaders meeting in Brussels had made progress on the te...
Synairgen's drug shows reduced risk of severe disease in COVID-19 patients
July 20 (Reuters) - Synairgen Plc said on Monday its drug helped reduce the risk of developing severe diseases in hospitalised COVID-19 patients, ac...
Synairgen treatment reduces risk of 'severe' Covid-19 by 79%
(Sharecast News) - Synairgen's Covid-19 treatment sharply reduced the risk of patients developing severe forms of the illness provoked by the novel co...
UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
IN BRIEF: Synairgen Expands Home Setting Trial Of Inhaled SNG001
IN BRIEF: Synairgen Expands Home Setting Trial Of Inhaled SNG001
Follow the stocks
